Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanborn

Showing results (881-890 of 996) with videos related to

Pageof 100
Sort By:
Nature|February 25, 2026
Human hippocampal neurogenesis in adulthood, ageing and Alzheimer's diseaseAhmed Disouky, Mark A Sanborn, K R Sabitha, et al.
The American Journal of Sports Medicine|October 20, 2021
Regional Differences in Anterior Cruciate Ligament Signal Intensity After Surgical TreatmentAta M Kiapour, Sean W Flannery, Martha M Murray, et al.
Cancer Immunology Research|July 12, 2019
Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial ImmunotherapyKarin L Lee, Stephen C Benz, Kristin C Hicks, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 1998
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heartC A Mack, S R Patel, E A Schwarz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2026
Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non-Small Cell Lung Cancer (ZEAL-1L)Suresh S Ramalingam, Vamsidhar Velcheti, Mehmet Altan, et al.
The Oncologist|July 21, 2021
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid TumorsKhanh T Do, Laura Quan Man Chow, Karen Reckamp, et al.
Pacing and Clinical Electrophysiology : PACE|September 4, 2019
A comparison of postprocedural anticoagulation in high-risk patients undergoing WATCHMAN device implantationJoshua A Cohen, E Kevin Heist, Jennifer Galvin, et al.
Science Translational Medicine|April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2020
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 TrialMakoto Nishio, Fabrice Barlesi, Howard West, et al.
Frontiers in Psychology|April 6, 2026
Medication adherence in thoracic transplant candidatesDavid M Sanborn, Kelly M Pennington, Roberto P Benzo, et al.
Pageof 100

Showing results (881-890 of 996) with videos related to

Sort By:
Pageof 100
Nature|February 25, 2026
Human hippocampal neurogenesis in adulthood, ageing and Alzheimer's diseaseAhmed Disouky, Mark A Sanborn, K R Sabitha, et al.
The American Journal of Sports Medicine|October 20, 2021
Regional Differences in Anterior Cruciate Ligament Signal Intensity After Surgical TreatmentAta M Kiapour, Sean W Flannery, Martha M Murray, et al.
Cancer Immunology Research|July 12, 2019
Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial ImmunotherapyKarin L Lee, Stephen C Benz, Kristin C Hicks, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 1998
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heartC A Mack, S R Patel, E A Schwarz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2026
Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non-Small Cell Lung Cancer (ZEAL-1L)Suresh S Ramalingam, Vamsidhar Velcheti, Mehmet Altan, et al.
The Oncologist|July 21, 2021
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid TumorsKhanh T Do, Laura Quan Man Chow, Karen Reckamp, et al.
Pacing and Clinical Electrophysiology : PACE|September 4, 2019
A comparison of postprocedural anticoagulation in high-risk patients undergoing WATCHMAN device implantationJoshua A Cohen, E Kevin Heist, Jennifer Galvin, et al.
Science Translational Medicine|April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2020
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 TrialMakoto Nishio, Fabrice Barlesi, Howard West, et al.
Frontiers in Psychology|April 6, 2026
Medication adherence in thoracic transplant candidatesDavid M Sanborn, Kelly M Pennington, Roberto P Benzo, et al.
Pageof 100